Catalyst Wire Dossier Catalyst Wire Dossier

IL-12

interleukin-12
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-12, covering 2022-01-19 to 2022-01-19. Get the full timeline:

Most recent: Clinical Trial Update: EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma [Phase 2]

See pricing